In response to my DDM simulation, the inventory's honest value is $158. That is about 36% larger than the present value ranges, which means the inventory has substantial upside potential. That mentioned,...
Offers and Financings Beijing’s BeiGene (BGNE; HK: 06160; SHA: 688235) acquired international rights to a preclinical novel cyclin-dependent kinase 2 (CDK2) inhibitor from Boston’s Ensem Therapeutics in a $1.3 billion...